Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shlomit Reich-Zeliger

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Blood|May 31, 2003
Anti-third-party veto CTLs overcome rejection of hematopoietic allografts: synergism with rapamycin and BM cell doseEsther Bachar-Lustig, Shlomit Reich-Zeliger, Yair Reisner
Journal of Immunology (Baltimore, Md. : 1950)|November 24, 2004
Tolerance induction by veto CTLs in the TCR transgenic 2C mouse model. I. Relative reactivity of different veto cellsShlomit Reich-Zeliger, Esther Bachar-Lustig, Judith Gan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 24, 2004
Tolerance induction by veto CTLs in the TCR transgenic 2C mouse model. II. Deletion of effector cells by Fas-Fas ligand apoptosisShlomit Reich-Zeliger, Judith Gan, Esther Bachar-Lustig, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2007
Tolerance induction in presensitized bone marrow recipients by veto CTLs: effective deletion of host anti-donor memory effector cellsShlomit Reich-Zeliger, Esther Bachar-Lustig, Avichai Bar-Ilan, et al.
Blood Cells, Molecules & Diseases|November 6, 2004
Crossing the HLA barriersYair Reisner, Hilit Gur, Shlomit Reich-Zeliger, et al.
Annals of the New York Academy of Sciences|June 12, 2003
Hematopoietic stem cell transplantation across major genetic barriers: tolerance induction by megadose CD34 cells and other veto cellsYair Reisner, Hilit Gur, Shlomit Reich-Zeliger, et al.
Journal for Immunotherapy of Cancer|June 12, 2024
Molecular mechanisms underlying the modulation of T-cell proliferation and cytotoxicity by immobilized CCL21 and ICAM1Sofi Yado, Bareket Dassa, Rawan Zoabi, et al.
Annals of the New York Academy of Sciences|June 17, 2005
Hematopoietic stem cell transplantation across major genetic barriers: tolerance induction by megadose CD34 cells and other veto cellsYair Reisner, Hilit Gur, Shlomit Reich-Zeliger, et al.
Transplantation|July 3, 2010
Deletion of alloreactive T cells by veto cytotoxic T lymphocytes is mediated through extracellular signal-regulated kinase phosphorylationShlomit Reich-Zeliger, Yaki Eidelstein, David Hagin, et al.
Frontiers in Immunology|June 16, 2023
Viral infection reveals hidden sharing of TCR CDR3 sequences between individualsMichal Mark, Shlomit Reich-Zeliger, Erez Greenstein, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Blood|May 31, 2003
Anti-third-party veto CTLs overcome rejection of hematopoietic allografts: synergism with rapamycin and BM cell doseEsther Bachar-Lustig, Shlomit Reich-Zeliger, Yair Reisner
Journal of Immunology (Baltimore, Md. : 1950)|November 24, 2004
Tolerance induction by veto CTLs in the TCR transgenic 2C mouse model. I. Relative reactivity of different veto cellsShlomit Reich-Zeliger, Esther Bachar-Lustig, Judith Gan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 24, 2004
Tolerance induction by veto CTLs in the TCR transgenic 2C mouse model. II. Deletion of effector cells by Fas-Fas ligand apoptosisShlomit Reich-Zeliger, Judith Gan, Esther Bachar-Lustig, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2007
Tolerance induction in presensitized bone marrow recipients by veto CTLs: effective deletion of host anti-donor memory effector cellsShlomit Reich-Zeliger, Esther Bachar-Lustig, Avichai Bar-Ilan, et al.
Blood Cells, Molecules & Diseases|November 6, 2004
Crossing the HLA barriersYair Reisner, Hilit Gur, Shlomit Reich-Zeliger, et al.
Annals of the New York Academy of Sciences|June 12, 2003
Hematopoietic stem cell transplantation across major genetic barriers: tolerance induction by megadose CD34 cells and other veto cellsYair Reisner, Hilit Gur, Shlomit Reich-Zeliger, et al.
Journal for Immunotherapy of Cancer|June 12, 2024
Molecular mechanisms underlying the modulation of T-cell proliferation and cytotoxicity by immobilized CCL21 and ICAM1Sofi Yado, Bareket Dassa, Rawan Zoabi, et al.
Annals of the New York Academy of Sciences|June 17, 2005
Hematopoietic stem cell transplantation across major genetic barriers: tolerance induction by megadose CD34 cells and other veto cellsYair Reisner, Hilit Gur, Shlomit Reich-Zeliger, et al.
Transplantation|July 3, 2010
Deletion of alloreactive T cells by veto cytotoxic T lymphocytes is mediated through extracellular signal-regulated kinase phosphorylationShlomit Reich-Zeliger, Yaki Eidelstein, David Hagin, et al.
Frontiers in Immunology|June 16, 2023
Viral infection reveals hidden sharing of TCR CDR3 sequences between individualsMichal Mark, Shlomit Reich-Zeliger, Erez Greenstein, et al.
Pageof 5